Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 158

Similar articles for PubMed (Select 20228782)

1.

Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase.

Sehdev AS, Kurman RJ, Kuhn E, Shih IeM.

Mod Pathol. 2010 Jun;23(6):844-55. doi: 10.1038/modpathol.2010.60. Epub 2010 Mar 12.

2.

Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.

Morrison JC, Blanco LZ Jr, Vang R, Ronnett BM.

Am J Surg Pathol. 2015 Apr;39(4):442-53. doi: 10.1097/PAS.0000000000000352.

PMID:
25517955
3.
4.

The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma.

Kuhn E, Kurman RJ, Soslow RA, Han G, Sehdev AS, Morin PJ, Wang TL, Shih IeM.

Am J Surg Pathol. 2012 Dec;36(12):1826-34. doi: 10.1097/PAS.0b013e31825ec07a.

5.

Are all pelvic (nonuterine) serous carcinomas of tubal origin?

Przybycin CG, Kurman RJ, Ronnett BM, Shih IeM, Vang R.

Am J Surg Pathol. 2010 Oct;34(10):1407-16. doi: 10.1097/PAS.0b013e3181ef7b16. Erratum in: Am J Surg Pathol. 2010 Dec;34(12):1891.

PMID:
20861711
6.

Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis.

Kuhn E, Meeker A, Wang TL, Sehdev AS, Kurman RJ, Shih IeM.

Am J Surg Pathol. 2010 Jun;34(6):829-36. doi: 10.1097/PAS.0b013e3181dcede7.

PMID:
20431479
7.

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions.

Kuhn E, Kurman RJ, Vang R, Sehdev AS, Han G, Soslow R, Wang TL, Shih IeM.

J Pathol. 2012 Feb;226(3):421-6. doi: 10.1002/path.3023. Epub 2011 Dec 23.

PMID:
21990067
8.

Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis.

Bijron JG, Seldenrijk CA, Zweemer RP, Lange JG, Verheijen RH, van Diest PJ.

Am J Surg Pathol. 2013 Aug;37(8):1123-30. doi: 10.1097/PAS.0b013e318282da7f.

PMID:
23648462
9.

[Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].

Liang Y, Chen XD, Lü BJ, Zhou CY, Zhang XF, Shi HY.

Zhonghua Fu Chan Ke Za Zhi. 2011 Oct;46(10):724-8. Chinese.

PMID:
22321343
10.

A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.

Sherman-Baust CA, Kuhn E, Valle BL, Shih IeM, Kurman RJ, Wang TL, Amano T, Ko MS, Miyoshi I, Araki Y, Lehrmann E, Zhang Y, Becker KG, Morin PJ.

J Pathol. 2014 Jul;233(3):228-37. doi: 10.1002/path.4353.

11.

High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.

Roh MH, Yassin Y, Miron A, Mehra KK, Mehrad M, Monte NM, Mutter GL, Nucci MR, Ning G, Mckeon FD, Hirsch MS, Wa X, Crum CP.

Mod Pathol. 2010 Oct;23(10):1316-24. doi: 10.1038/modpathol.2010.119. Epub 2010 Jun 18.

12.

The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors.

Altman AD, Nelson GS, Ghatage P, McIntyre JB, Capper D, Chu P, Nation JG, Karnezis AN, Han G, Kalloger SE, Köbel M.

Mod Pathol. 2013 Sep;26(9):1255-63. doi: 10.1038/modpathol.2013.55. Epub 2013 Apr 5.

13.

Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma.

Kuhn E, Kurman RJ, Sehdev AS, Shih IeM.

Int J Gynecol Pathol. 2012 Sep;31(5):416-22. doi: 10.1097/PGP.0b013e31824cbeb4.

14.

Morphological and immunohistochemical pattern of tubo-ovarian dysplasia and serous tubal intraepithelial carcinoma.

Chene G, Cayre A, Raoelfils I, Lagarde N, Dauplat J, Penault-Llorca F.

Eur J Obstet Gynecol Reprod Biol. 2014 Dec;183:89-95. doi: 10.1016/j.ejogrb.2014.10.003. Epub 2014 Oct 14.

PMID:
25461359
15.

[Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].

Wen J, Shi JL, Shen DH, Chen YX, Song QJ.

Zhonghua Bing Li Xue Za Zhi. 2012 Jul;41(7):433-7. doi: 10.3760/cma.j.issn.0529-5807.2012.07.001. Chinese.

PMID:
22932451
16.

Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas.

Horn LC, Kafkova S, Leonhardt K, Kellner C, Einenkel J.

Int J Gynecol Pathol. 2013 Jul;32(4):339-44. doi: 10.1097/PGP.0b013e31826a629b.

PMID:
23722505
17.

Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.

Lee YH, Heo JH, Kim TH, Kang H, Kim G, Kim J, Cho SH, An HJ.

Int J Gynecol Pathol. 2011 May;30(3):205-17. doi: 10.1097/PGP.0b013e3182063e71.

PMID:
21464733
18.

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD, Crum CP.

J Pathol. 2007 Jan;211(1):26-35. Erratum in: J Pathol. 2007 Sep;213(1):116.

PMID:
17117391
19.

p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.

Leonhardt K, Einenkel J, Sohr S, Engeland K, Horn LC.

Int J Gynecol Pathol. 2011 Sep;30(5):417-24. doi: 10.1097/PGP.0b013e318216d447.

PMID:
21804388
20.

Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin?

Gao FF, Bhargava R, Yang H, Li Z, Zhao C.

Hum Pathol. 2013 Aug;44(8):1534-43. doi: 10.1016/j.humpath.2012.12.007. Epub 2013 Mar 1.

PMID:
23465279
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk